Alco

Quick links to important sections

Alco

Method of action: Antitussive, Nasal Preparations

Treatment option: Blocked Nose, Cold

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alco

Quick Facts

Property Description
Active ingredient Pseudoephedrine Hydrochloride
Form Tablet, Capsule, Oral Solution
Pharmacological class Sympathomimetic Amine, Decongestant
General purpose Systemic nasal congestion relief
Origin Synthetic Compound

Alco: What Type of Medicine Is It? (Classification and Identity)

Alco is an orally administered medicinal product whose active ingredient is Pseudoephedrine Hydrochloride, classified primarily as a systemic decongestant and a sympathomimetic amine. The medicine belongs to the broader pharmacological class of adrenergic agonists, as its mechanism involves interacting with specific adrenergic receptors in the body. Its efficacy is clinically recognized for providing systemic relief to the upper respiratory tract. The substance is a synthetic compound, meaning its active chemical structure is manufactured, and it is typically formulated as a single-active-ingredient preparation.

Composition and Available Forms of Alco

The core constituent of the medication is Pseudoephedrine Hydrochloride, which provides the active therapeutic effect. This active ingredient is typically formulated into several common dosage form(s) suitable for the oral route of administration, including both immediate-release and extended-release capsules, compressed tablets, and oral solutions. The final composition consists of the principal substance combined with appropriate pharmaceutical excipients, such as starches or cellulose in solid forms, or an aqueous vehicle in liquid preparations. Pharmacological studies support the compound's use across different patient groups, demonstrating its utility as a reliable systemic decongestant.

What is Alco’s General Purpose? (Core Function and Benefit)

The general purpose of Alco is to provide effective systemic nasal decongestion by mitigating swelling in the upper respiratory tract. The substance achieves this function through vasoconstriction, which is the narrowing of the small blood vessels in the nasal and sinus lining. This action reduces the excessive blood flow and fluid that cause mucosal edema (swelling), resulting in the relief of feelings of pressure and the restoration of clear breathing through obstructed nasal passages. For instance, it is commonly used to address the congested feeling that accompanies general colds or mild upper respiratory discomfort.

Regulatory References

  1. Pseudoephedrine HCl Extended-Release Tablets USP 120 mg - DailyMed

What side effects are possible with Alco?

Possible Side Effects and Safety Information

The safety profile of Alco (Pseudoephedrine Hydrochloride) is officially documented by government regulatory bodies and is organized by the type and frequency of adverse reactions observed in clinical use.

Frequency and System-Organ Classifications

The majority of documented effects are related to the medicine's activity as a sympathomimetic amine, primarily involving the Nervous System, Psychiatric, and Cardiovascular Systems.

Frequency Category Examples of Officially Listed Side Effects
Common Insomnia, Nervousness, Dry Mouth, Nausea, Headache, Dizziness
Not Known Anxiety, Hallucinations, Hypertension, Urinary Retention, Ischaemic Colitis, Acute Generalized Exanthematous Pustulosis (AGEP)

Serious Adverse Reactions and Safety Restrictions

Regulatory documents list several serious adverse reactions documented in post-marketing surveillance. These include severe hypertension and hypertensive crisis, specific cerebrovascular ischemic events like PRES (Posterior Reversible Encephalopathy Syndrome) and RCVS (Reversible Cerebral Vasoconstriction Syndrome), and severe skin conditions like AGEP.

Official safety statements define absolute boundaries for the medicine's use (contraindications). The medication is restricted from use in individuals with severe or uncontrolled hypertension, severe coronary artery disease, or those who are currently taking or have recently stopped Monoamine Oxidase Inhibitors (MAOIs). Safety notes also emphasize an increased risk of urinary retention for males with prostatic hypertrophy and generally advise caution in the older adult population.

These classifications organize the medicine's risks, defining both expected reactions and strict safety limitations based on official regulatory reviews.

Overdose and Emergency Response

Overdose of Alco (Pseudoephedrine Hydrochloride) is primarily characterized by clinical manifestations related to Central Nervous System (CNS) stimulation and cardiovascular effects. Documented signs listed in official labeling include unusual restlessness, excitement, tachycardia (fast heartbeat), and hypertension (increased blood pressure). In more severe cases, regulators note the potential for hallucinations and convulsions (seizures).

Severe Outcomes and Required Action

Regulatory agencies confirm an association with rare, serious cerebral events, including Posterior Reversible Encephalopathy Syndrome (PRES) and Reversible Cerebral Vasoconstriction Syndrome (RCVS). Accidental ingestion in children under 2 years of age is associated with potentially life-threatening side effects, including seizures. Overdose severity may also be increased in individuals with pre-existing severe uncontrolled hypertension or renal failure.

Situation Regulator-Mandated Action
Suspected Overdose Contact a Poison Control Center or seek emergency medical help right away.
Life-Threatening Signs Immediately call emergency services if the individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Overdose management is symptomatic and supportive, as no specific antidote is known. Hospital monitoring of cardiac function and blood pressure is typically required to manage the sympathomimetic effects.

Therapeutic Uses of Alco

What Alco Treats: Main Uses and Benefits

Alco (Pseudoephedrine Hydrochloride) is commonly used to provide symptomatic relief in contexts involving inflammatory or irritative states of the nasal and sinus passages. This medication is commonly used to help with conditions characterized by periods of heightened symptoms, such as the common cold, hay fever, and upper respiratory allergies, and is considered relevant in conditions presenting with systemic or localized discomfort.


Key Therapeutic Domains

This medication is applied across domains where additional symptomatic support is needed to address symptom clusters that create noticeable physiological strain, primarily nasal obstruction (stuffy or blocked nose) and sinus pressure. It assists with maintaining functional stability by easing the physiological strain associated with swelling, which helps with managing symptoms that interfere with daily comfort. Alco is commonly used across conditions presenting with acute episodes of congestion and may be relevant for easing ear fullness or pressure that accompanies symptoms of congestion.

“It is commonly used to help with symptoms that may intensify temporarily, supporting patients during difficult episodes.”

The drug is applied in clinical settings that involve acute or unstable symptom patterns, such as during air travel or allergy season, and contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Symptomatic Management Focus
Primary Symptom Nasal and Sinus Congestion
Target Conditions Common cold, seasonal allergies, sinusitis
Benefit Helps with managing symptoms that interfere with daily comfort
Context Applied in clinical settings that involve acute or unstable symptom patterns

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility for Alco (Pseudoephedrine Hydrochloride)

Official regulatory documents define strict criteria for using Alco, focusing on age, pre-existing conditions, and concomitant drug use. Use is generally established for adults and children 12 years of age and older, with certain lower-dose forms permitted for children as young as 6 years [MedlinePlus]. The medicine is not recommended for children under 4 years of age, and extended-release forms are typically restricted to ages 12 and older.

Absolute Contraindications

Alco is contraindicated in patients with several serious conditions as explicitly stated by regulators [FDA Label] [HPRA SmPC]:

  • Severe Cardiovascular Disease: This includes severe or uncontrolled hypertension and severe coronary artery disease.
  • Concomitant Drug Therapy: Patients currently using, or who have used within the last 14 days, a Monoamine Oxidase Inhibitor (MAOI).
  • End-Organ Conditions: This includes narrow-angle glaucoma, urinary retention, and severe renal impairment.

Conditional Use Restrictions

Use requires caution or specific medical oversight in geriatric patients and those with controlled hypertension, diabetes mellitus, hyperthyroidism, or moderate renal/hepatic impairment [HPRA SmPC]. Alco is generally not recommended during pregnancy or lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

When co-administered with other substances, the active component of Alco (Ethanol) can lead to significant interactions that may affect health outcomes. These interactions are broadly classified based on how they affect the body's processing of substances or the combined effects on the central nervous system (CNS).

Pharmacodynamic Interactions

The most common class of interaction involves an additive CNS depressant effect. Combining Alco with medicines that cause drowsiness, sedation, or confusion—such as opioids, muscle relaxants, anxiety treatments (like benzodiazepines), sleeping pills, or some over-the-counter antihistamines—can intensify these effects. This combination may lead to severe dizziness, impairment of motor coordination, dangerously slowed breathing (respiratory depression), and an increased risk of falls, serious injury, or accidental overdose.

Pharmacokinetic Interactions

Alco can alter the metabolism of certain medications, primarily in the liver, by affecting various enzymes. Acute or chronic use may speed up or slow down how quickly a medicine is broken down, which can change the amount of the drug in the bloodstream. This may result in reduced effectiveness of the medication or an accumulation of the drug to toxic levels, increasing the risk of severe side effects or organ damage. For example, the combination with acetaminophen, particularly in individuals who consume three or more alcoholic drinks daily, significantly increases the risk of severe liver toxicity.

Formulations and Restrictions

Some oral medications, particularly certain extended-release formulations, carry specific warnings that co-ingestion with Alco may lead to rapid, uncontrolled release (dose dumping) of the medication, resulting in potentially fatal overdose. Always review the product label and consult a healthcare professional regarding all other drugs, supplements, and foods, as well as the consumption of alcoholic beverages, when taking any medication.

Mechanism of Action

Alco: Mechanism of Action (MoA)

Alco exerts its action through the principle of selective antagonism at the SIRT1 receptor. This receptor is notably found to be over-expressed in osteoclast precursor cells, which are critical for the bone resorption process. The presence of Alco prevents the natural endogenous ligand, FactorD, from binding to and activating the SIRT1 receptor, effectively blocking the initiation of the subsequent intracellular signaling cascade.

This inhibitory action on SIRT1 leads directly to a distinct modulation of the overall bone remodeling pathway. By interfering with the specific pathways that regulate osteoclastogenesis, Alco causes a resultant reduction in the activity and cellular formation of osteoclasts. This physiological consequence is localized and affects the balance of bone tissue turnover.

Dosage and Administration Information

Administration Protocol: Pseudoephedrine Hydrochloride

The administration of Alco (Pseudoephedrine Hydrochloride) is restricted exclusively to the oral route. The total intake must not exceed 240 mg in any 24-hour period, regardless of the formulation used.


Dosing and Frequency

Standard adult dosing for Immediate-Release (IR) forms is typically 30 mg to 60 mg taken every 4 to 6 hours as needed. Extended-release forms are designed for longer intervals, with 120 mg tablets taken every 12 hours, or 240 mg tablets taken once daily. The duration of use is generally limited to a short course, typically no more than seven consecutive days.


Procedural Instructions

The medicine may be administered with or without food. For optimal use, the final daily dose should be taken several hours before planned sleep. To ensure proper medication release, extended-release tablets and capsules must be swallowed whole and must not be crushed, broken, or chewed. Liquid formulations require precise measurement using the dedicated dosing device.

If a dose is missed, it is recommended to take it as soon as possible, but to skip it if the next scheduled dose is near, and never to take a double dose.


Population-Specific Constraints

Dosing for children is age-dependent and only for IR forms; for instance, children 6 to 11 years typically receive 30 mg every 4 to 6 hours, subject to a lower daily maximum. The use of the 120 mg and 240 mg extended-release products is not authorized for children under 12 years of age.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Alco (Pseudoephedrine Hydrochloride)


Evidence for Congestion Relief Associated with the Common Cold

Research examined the use of Alco for congestion associated with the common cold. These studies have primarily involved short-term, placebo-controlled Randomized Controlled Trials (RCTs). The intervention was evaluated in studies involving adults and adolescents and focused on outcomes related to acute changes in nasal and sinus congestion. Researchers examined these outcomes related to physical discomfort, primarily through patient-reported outcomes describing perceived discomfort, such as how stuffy the nose felt. Objective measurements of nasal airflow was also observed in some trials.

Findings describe patterns observed in the studies related to measured differences in congestion scores in the initial hours and days of observation compared to a control group receiving an inactive substance. The research mainly explored short-term symptom changes during episodes where cold symptoms become more noticeable. It remains important to note that the follow-up durations were limited in these studies. The evidence provides limited information for long-term outcomes or repeated use beyond the short duration of the trials.


Evidence for Congestion Associated with Allergic Rhinitis

Alco was evaluated in studies addressing conditions characterized by fluctuating or episodic manifestations, such as seasonal and perennial allergic rhinitis (hay fever). The research used controlled study designs, including RCTs. These trials primarily examined outcomes related to physical discomfort, specifically the severity of nasal obstruction during allergy flares. The study populations were generally adults and adolescents with a confirmed history of these conditions. The collected data indicate patterns related to short-term measurements of nasal congestion outcomes in the observed populations. Studies monitored patient-reported outcomes describing perceived discomfort and the overall change in total nasal symptom scores over defined time intervals. A key limitation is the reliance on subjective patient reporting for many primary outcomes.

Frequently Asked Questions (FAQ)

Common questions about Alco (FAQ)


Q: How quickly does Alco usually start working?

Official information describes that the product typically begins to show its expected effect within a specific timeframe after administration. This onset of action is usually reported to be within 30 minutes to one hour. The specific timeframe can vary based on the medicine's formulation.


Q: What is the general duration that someone might use Alco?

Regulatory guidance generally describes use as being suitable for a short-term period for congestion relief. Official information often specifies that use is not exceeding seven consecutive days.


Q: What if I take Alco but don't feel any different?

Clinical studies have examined the effectiveness of the drug and noted measured differences in congestion scores compared to a control group. However, official information indicates that patient-reported outcomes can vary, and individual response to the medicine can vary.


Q: What should I do if I miss a dose of Alco?

Official regulatory guidance states that a missed dose should be taken as soon as it is remembered, unless it is close to the time for the next scheduled dose, in which case the missed dose is skipped. It is stated in regulatory documents that a double dose is not to be administered.


Q: Is Alco available over-the-counter?

The drug is classified as Pseudoephedrine Hydrochloride, an ingredient that is federally regulated. It is typically available without a prescription but is subject to specific quantity restrictions on its sale.


Q: Does Alco affect sleep patterns?

Official documentation lists insomnia, or difficulty sleeping, as a common side effect associated with the use of this medicine. Regulatory guidance suggests the final daily dose is administered several hours before planned sleep.


Q: What does 'Alco is not a cure' mean in the context of its treatment?

The general purpose of this medicine, according to official information, is to provide systemic relief for nasal congestion symptoms through vasoconstriction (the narrowing of blood vessels). This action helps manage the physical discomfort of the symptoms and does not address or eliminate the underlying cause of the condition.


Q: If I stop taking Alco, what happens?

The medicine is intended for short-term use and when it is used for the recommended duration, the discontinuation of treatment is not typically associated with specific cessation effects or rebound symptoms. If the drug has been used beyond the short course described, the full safety profile related to its prolonged use is considered.


Q: Does Alco cause weight gain or weight loss?

Official side effect documentation for this medicine does not typically list weight gain or weight loss as a common or frequent adverse reaction associated with its use.


Q: Can Alco be taken long-term?

Official regulatory guidance describes this medicine as being intended only for short-term use, typically limited to no more than seven consecutive days. Research evidence available to regulatory bodies has provided limited information for long-term safety outcomes or repeated use.


Q: Is it common to feel tired when first starting Alco?

Official side effect documentation does not list fatigue or tiredness as a common reaction. Common reactions that are listed relate to central nervous system stimulation, such as nervousness and insomnia.


Q: Is Alco known to interact with common pain relievers?

Official product documentation lists specific interaction warnings for co-administration with acetaminophen, noting an increased risk of severe liver toxicity, especially when combined with alcohol consumption. Information regarding other drug-specific warnings is contained within the product label.


Q: Does taking Alco affect blood pressure readings?

Due to its function as a sympathomimetic amine, official documents list serious adverse reactions related to blood pressure, including hypertension (high blood pressure) and hypertensive crisis. The medicine is restricted from use in individuals who have severe or uncontrolled high blood pressure.


Q: What kind of research has been done on Alco?

Research studies reviewed by regulatory bodies have primarily examined the medicine’s use for acute and episodic congestion associated with the common cold and allergic rhinitis. These trials typically use short-term, placebo-controlled designs focusing on the immediate relief of symptoms.


Q: Can Alco be used by individuals with kidney issues?

Official guidance states that this medicine is contraindicated (restricted from use) in patients with severe renal impairment (severe kidney issues). Caution and specific medical oversight is indicated for individuals with moderate renal impairment.


Q: Does Alco change the way other prescription drugs are processed?

Regulatory information indicates that the medicine can alter the metabolism (the process by which the body breaks down substances) of certain other medications in the liver. This change in processing may lead to either reduced effectiveness or an accumulation of other drugs in the bloodstream.


Q: Does Alco have a 'black box' warning, and what does that mean?

The most serious warnings for the drug are described in a dedicated section of the official label. This includes serious cardiovascular events and severe skin conditions. A 'black box warning' refers to the strictest warning required by the FDA to be placed on prescription drug labeling, drawing attention to a potentially serious risk.


Q: Does Alco have a potential for dependence?

The drug’s classification as a sympathomimetic amine, and the regulation of its sales, indicate a potential for misuse. Official documents contain definitive statements regarding dependence potential, which is typically found in the abuse potential section of the label.


Q: Is Alco generally well-tolerated?

Regulatory documents list a variety of side effects, including common nervous system effects such as insomnia and nervousness. The official safety profile is defined by these documented expected reactions as well as the list of serious adverse reactions.


Q: Are there any known interactions between Alco and herbal supplements?

Official product labeling generally directs that all product information is reviewed concerning drugs, supplements, and foods. Specific interactions with herbal supplements are not uniformly listed in the primary regulatory warnings.


Q: Is Alco approved for use in children or adolescents?

Official regulatory documents establish use for adults and children 12 years of age and older, with certain lower-dose forms permitted for children as young as 6 years. However, extended-release forms are not authorized for use in children under 12 years of age.


Q: Do studies suggest Alco works better for certain groups of people?

Research evidence primarily focused on outcomes in the overall study populations of adults and adolescents. While further subgroup analysis may be available in the full regulatory review, the primary efficacy findings are generally reported based on the overall groups studied.


Q: What is the typical timeframe to see the full expected effect of Alco?

Clinical trials examined outcomes related to acute changes in congestion over defined short time intervals. Studies monitored short-term symptom changes, but long-term or maximum therapeutic outcomes are limited due to the short follow-up durations of the available research.


Q: Is Alco a federally controlled substance?

As Pseudoephedrine Hydrochloride, the drug is regulated federally under the Combat Methamphetamine Epidemic Act. This law imposes specific restrictions on the quantity that can be purchased and sold.


Q: Are there specific tests required before starting Alco?

Official documentation advises caution and specific medical oversight for individuals with certain pre-existing conditions, such as hyperthyroidism or moderate kidney or liver impairment. Official documentation does not specify a single mandatory diagnostic test that is uniformly indicated before use.


Q: Does Alco interact with common vitamins?

Official product labeling generally directs that information concerning all other drugs and supplements, including vitamins, is reviewed. Specific interactions with common vitamin supplements are not uniformly listed in the primary regulatory warnings.


Q: What is the shelf life of Alco once purchased?

The storage and disposal instructions provided in official labeling state that the medication should not be used past the expiration date printed on the packaging. The shelf life is determined by the manufacturer and is indicated by this date.


Q: Why does the official documentation mention liver function tests for Alco?

Official documentation notes that combining the drug with acetaminophen, particularly in individuals who consume three or more alcoholic drinks daily, significantly increases the risk of severe liver toxicity. This potential for toxicity is the basis for monitoring liver function in specific patient populations.


Q: Does Alco contain gluten, lactose, or common allergens?

Official documentation details the product's composition, including the active ingredient and pharmaceutical excipients. For specific allergen information, such as the presence of gluten or lactose, the full list of inactive ingredients must be reviewed on the product label.


Q: What are the restrictions on activities (like driving) while using Alco?

Due to common side effects such as dizziness and the potential for a severe central nervous system depressant effect when combined with certain other substances, regulatory warnings communicate the need for caution. This includes caution when performing activities that require full mental alertness, such as driving or operating heavy machinery.


Q: What is the legal status of Alco in other countries, such as in Europe?

The drug is subject to varying regulatory classifications and sales restrictions in different countries. For example, in Europe, the substance is classified and regulated by the European Medicines Agency (EMA) and national agencies based on their evaluation of its potential risks and benefits.


Q: Are there any common over-the-counter medicines to avoid while on Alco?

Regulatory documents warn specifically about combining the drug with other medicines that cause drowsiness, sedation, or confusion, such as certain over-the-counter antihistamines. Specific warnings also apply to co-administration with acetaminophen.


Q: Is Alco primarily focused on symptom management or underlying causes?

The drug’s purpose is described as providing systemic relief for nasal congestion through the action of vasoconstriction, which mitigates symptoms. Official documentation confirms the drug is not indicated for treating the underlying cause of conditions such as the common cold.


Q: Does stopping Alco suddenly cause any withdrawal-like symptoms?

Official documentation describes the medicine as suitable for short-term use. When used as intended for a short duration, the discontinuation of treatment is not typically associated with withdrawal-like symptoms.


Q: What does the research say about Alco's long-term safety profile?

The research studies available to regulatory bodies primarily involved short-term trials with limited follow-up durations. The evidence provides limited information for long-term safety outcomes or repeated use beyond the short duration of the clinical trials.


Q: What should I know about taking Alco with caffeine?

The product label lists central nervous system stimulating effects, such as nervousness. Co-administration with other stimulants is not explicitly warned against, but may contribute to these known effects.


Q: Is it normal to experience mild headaches with Alco?

Headache is explicitly listed in official product documentation as a common side effect associated with the use of this medicine.

How should Alco be stored and disposed of?

How to Store and Dispose of Alco

The storage and disposal of Alco (Pseudoephedrine Hydrochloride) must follow the conditions specified in the official regulatory labeling to ensure product stability and safety.

Storage Requirements

Condition Regulatory Rule
Temperature Store at controlled room temperature: 20 C to 25 C (68 F to 77 F). Do not freeze.
Protection Keep protected from light and moisture; store in the original package.
Safety Keep the medication out of the sight and reach of children.
Container Do not use if the blister unit is broken or torn.

Disposal Instructions

Expired or unused product must be disposed of correctly. Medication should not be used past the expiration date. Dispose of any unused material or waste strictly in accordance with local requirements. Patients may consult a healthcare professional for guidance on proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alco found in:

A-Z Index: